Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a human spine and muscle fibers for musculoskeletal care.

Aug 11, 2026

Analysis of Flagler Health's $50 Million Series B Round: Capitalising the AI Operating System for Musculoskeletal Care

Flagler Health has successfully raised $50 million in a Series B funding round, marking a significant milestone in the development of its AI-driven platform tailored for musculoskeletal (MSK) care.This latest round of financing, led by Bessemer Venture Partners and supported by various institutional investors, brings Flagler Health's total capital raised to $63 million. The investment signifies a pivotal shift in digital health, moving towards comprehensive AI operating systems that enhance exis
A test tube with a colorful liquid in a dimly lit lab setting.

Aug 11, 2026

Elemental Machines Unveils Resources Manager for Life Sciences Labs

Elemental Machines has launched Resources Manager, an innovative asset intelligence platform aimed at enhancing operational efficiency in life sciences laboratories.This new platform allows lab teams to transcend basic asset monitoring by integrating critical operational elements such as asset information, scheduling, and record storage into a single, comprehensive view. Resources Manager is designed to either complement existing enterprise asset management systems or function independently, mak
A skin sample in a dermatology lab

Aug 11, 2026

AI diagnostics and biotech reshape the future of personalized beauty, says Revieve

AI-driven diagnostics are revolutionizing the beauty industry, shifting focus towards personalized, data-informed consumer experiences.Recent insights from Revieve's report, "The Future Face of Beauty," highlight a significant transition in consumer expectations. Today's buyers prioritize reliability and personalization, driven by advanced technologies like AI diagnostics, which are transforming product development and marketing strategies. Brands are now expected to provide not just effective p
Press release cover image

Aug 11, 2026

Press release

Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination

Nature Communications study finds UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methodsFindings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impactStudy defines sequencing, replication and process-control conditions relevant to
Press release cover image

Aug 11, 2026

Press release

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

New offering integrates virtual clinicians to create a scalable channel to increase availability of GeneDx exome testing for eligible children facing specialty-care barriersGAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced the launch of a new online offering designed to expand accessibility of exome testing across the U.S. at scale for pediatric patients with global developmental
A minimalist representation of a biomarker with a cloud icon, symbolizing digital diagnostics.

Aug 11, 2026

Digital Companion Diagnostics Software Market to Reach $5.1Bn by 2036, Led by Cloud-based Companion Diagnostics Software

The digital companion diagnostics software market is poised for significant growth, projected to increase from $1.4 billion in 2026 to $5.1 billion by 2036, reflecting a compound annual growth rate (CAGR) of 13.8%.This expansion is largely driven by the rising need for precision medicine, which necessitates software that can efficiently translate biomarker results into actionable treatment recommendations. Cloud-based solutions are currently leading the market, accounting for 41% of demand, whil
Press release cover image

Aug 11, 2026

Press release

Bioxytran Reports Encouraging Clinical Observations in First Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Treated with PLICID, a Novel Galectin Antagonist Designed with Artificial Intelligence

Once-weekly intravenous treatment was associated with reported improvements in finger function and walking ability, with no adverse events reported during treatment BOSTON, MA, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company pioneering galectin-targeting carbohydrate therapeutics, today announced positive clinical results from the first patient treated with PLICID, an investigational galectin antagonist for Chronic Inflammatory Demyelinat
Minimalist illustration of a colposcope

Aug 11, 2026

TDB Partners with Griva Healthcare to Expand AI-powered Cancer Screening with 'GrivaVision'

The Technology Development Board (TDB) has partnered with Griva Healthcare to enhance early cancer screening through the introduction of the AI-powered portable digital colposcope, GrivaVision.This collaboration aims to facilitate the manufacturing and commercialization of GrivaVision, a device designed to assist gynecologists in visualizing the vaginal canal and examining cervical lesions effectively. With features like a high-definition camera and advanced optics, GrivaVision integrates indige
A flat illustration of a glucose monitoring device

Aug 11, 2026

Abbott teams with Google Health on AI-powered health insights app

Abbott and Google Health have announced a groundbreaking partnership aimed at enhancing personal health management through advanced technology.The collaboration combines Abbott’s Lingo glucose monitoring device with Google Health’s artificial intelligence capabilities to deliver tailored metabolic insights within the Google Health app. This integration allows users to track glucose levels alongside various health metrics, fostering a better understanding of how daily habits impact overall wellne
Petri dish with bacterial culture in a dimly lit lab

Aug 10, 2026

Bacterial Trait-Finding and Gene Mapping Platform Speeds Microbial Engineering for Biotech Applications

Researchers at Oak Ridge National Laboratory have developed a novel platform that enhances microbial engineering by identifying genetic triggers that transform bacteria into efficient producers of valuable chemicals and materials.This innovative platform utilizes a blend of synthetic biology, artificial intelligence, and statistical mapping to pinpoint specific genetic factors responsible for complex traits in microbes. This advancement allows for the precise reprogramming of bacteria, potential
Flat design of a patent application document with an import arrow

Aug 10, 2026

Webinar: AI Capabilities and the Future in Life Sciences Patent Practice

A recent webinar hosted by Solve Intelligence will explore the current state and future trajectory of AI in life sciences patent practice.The session will feature insights from Solve’s patent attorney team, focusing on the latest advancements in AI technology tailored to life sciences workflows. Participants can expect demonstrations of new features that enhance sequence handling and data import, which are integral to drafting patent applications and constructing claim charts. The team will also
A minimalist representation of a cancer cell in a dark color scheme.

Aug 10, 2026

Ex-BioNTech execs launch 'AI-native' cancer company

Two former BioNTech executives have launched Bios Life, an innovative biotech company focused on AI-driven cancer surveillance aimed at enhancing care for high-risk individuals and cancer survivors.At the helm of Bios Life is Ryan Richardson, the former chief strategy officer at BioNTech, now serving as CEO. The company has secured $25 million in seed funding from investors including Redmile, Vsquared Ventures, and Kindred Capital. Zach Taylor, previously a senior vice president at BioNTech, has